Application 207534

Type: NDA
Sponsor: ADAMIS PHARMS CORP

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	SYMJEPI	EPINEPHRINE	SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS	0.3MG/0.3ML (0.3MG/0.3ML)	Yes	Yes
002	SYMJEPI	EPINEPHRINE	SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS	0.15MG/0.3ML (0.15MG/0.3ML)	Yes	Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N207534-001	SYMJEPI	EPINEPHRINE	0.3MG/0.3ML (0.3MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS		RLD, RS	2017-06-15
N207534-002	SYMJEPI	EPINEPHRINE	0.15MG/0.3ML (0.15MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS		RLD	2018-09-27

Orange Book patents#

Current patent rows page 1 of 1 · 2 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N207534-001	11141540	2036-10-20	U-3379	Drug product	2022-06-16
N207534-002	11141540	2036-10-20	U-3379	Drug product	2022-06-16

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N207534-001	SYMJEPI	0.3MG/0.3ML (0.3MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD, RS	2017-06-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N207534-002	SYMJEPI	0.15MG/0.3ML (0.15MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD	2018-09-27	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N207534-001	SYMJEPI	0.3MG/0.3ML (0.3MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD, RS	2017-06-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N207534-002	SYMJEPI	0.15MG/0.3ML (0.15MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD	2018-09-27	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N207534-001	SYMJEPI	0.3MG/0.3ML (0.3MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD, RS	2017-06-15	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N207534-002	SYMJEPI	0.15MG/0.3ML (0.15MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD	2018-09-27	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N207534-001	SYMJEPI	0.3MG/0.3ML (0.3MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD, RS	2017-06-15	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N207534-002	SYMJEPI	0.15MG/0.3ML (0.15MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD	2018-09-27	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N207534-001	SYMJEPI	0.3MG/0.3ML (0.3MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD, RS	2017-06-15	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N207534-002	SYMJEPI	0.15MG/0.3ML (0.15MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD	2018-09-27	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N207534-001	SYMJEPI	0.3MG/0.3ML (0.3MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD, RS	2017-06-15	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N207534-002	SYMJEPI	0.15MG/0.3ML (0.15MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD	2018-09-27	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N207534-001	SYMJEPI	0.3MG/0.3ML (0.3MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD, RS	2017-06-15	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N207534-002	SYMJEPI	0.15MG/0.3ML (0.15MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD	2018-09-27	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N207534-001	SYMJEPI	0.3MG/0.3ML (0.3MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD, RS	2017-06-15	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N207534-002	SYMJEPI	0.15MG/0.3ML (0.15MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD	2018-09-27	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N207534-001	SYMJEPI	0.3MG/0.3ML (0.3MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD, RS	2017-06-15	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N207534-002	SYMJEPI	0.15MG/0.3ML (0.15MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD	2018-09-27	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N207534-001	SYMJEPI	0.3MG/0.3ML (0.3MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD, RS	2017-06-15	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N207534-002	SYMJEPI	0.15MG/0.3ML (0.15MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD	2018-09-27	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N207534-001	SYMJEPI	0.3MG/0.3ML (0.3MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD, RS	2017-06-15	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N207534-002	SYMJEPI	0.15MG/0.3ML (0.15MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD	2018-09-27	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N207534-001	SYMJEPI	0.3MG/0.3ML (0.3MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD, RS	2017-06-15	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N207534-002	SYMJEPI	0.15MG/0.3ML (0.15MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD	2018-09-27	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N207534-001	SYMJEPI	0.3MG/0.3ML (0.3MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD, RS	2017-06-15	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N207534-002	SYMJEPI	0.15MG/0.3ML (0.15MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD	2018-09-27	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N207534-001	SYMJEPI	0.3MG/0.3ML (0.3MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD, RS	2017-06-15	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N207534-002	SYMJEPI	0.15MG/0.3ML (0.15MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD	2018-09-27	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N207534-001	SYMJEPI	0.3MG/0.3ML (0.3MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD, RS	2017-06-15	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N207534-002	SYMJEPI	0.15MG/0.3ML (0.15MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD, RS	2018-09-27	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N207534-001	SYMJEPI	0.3MG/0.3ML (0.3MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD, RS	2017-06-15	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N207534-002	SYMJEPI	0.15MG/0.3ML (0.15MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD, RS	2018-09-27	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N207534-001	SYMJEPI	0.3MG/0.3ML (0.3MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD, RS	2017-06-15	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N207534-002	SYMJEPI	0.15MG/0.3ML (0.15MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD, RS	2018-09-27	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N207534-001	SYMJEPI	0.3MG/0.3ML (0.3MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD, RS	2017-06-15	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N207534-002	SYMJEPI	0.15MG/0.3ML (0.15MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD, RS	2018-09-27	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N207534-001	SYMJEPI	0.3MG/0.3ML (0.3MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD, RS	2017-06-15	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N207534-002	SYMJEPI	0.15MG/0.3ML (0.15MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD, RS	2018-09-27	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N207534-001	SYMJEPI	0.3MG/0.3ML (0.3MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD, RS	2017-06-15	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N207534-002	SYMJEPI	0.15MG/0.3ML (0.15MG/0.3ML)	SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS	RLD, RS	2018-09-27	`782e0a99824c…`

Observed Orange Book patent history#

Patent history page 1 of 2 · 56 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N207534-001	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N207534-002	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N207534-001	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N207534-002	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N207534-001	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N207534-002	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N207534-001	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N207534-002	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N207534-001	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N207534-002	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N207534-001	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N207534-002	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N207534-001	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N207534-002	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N207534-001	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N207534-002	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N207534-001	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N207534-002	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N207534-001	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N207534-002	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N207534-001	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N207534-002	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N207534-001	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N207534-002	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N207534-001	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N207534-002	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N207534-001	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N207534-002	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`8072bd15b7f6…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N207534-001	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`6a51e52b5d6a…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N207534-002	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N207534-001	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`1c564ffb4f44…`
2024-02-18 07:12 UTC	2024-02	N207534-002	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N207534-001	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`ea1830bbd6c7…`
2023-12-20 04:57 UTC	2023-12	N207534-002	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N207534-001	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`a72a2bbeb626…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N207534-002	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N207534-001	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`9b2671bbb829…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N207534-002	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N207534-001	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`a67488948f0b…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N207534-002	11141540	2036-10-20	U-3379	Drug product	2022-06-16	`a67488948f0b…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 5 · 81 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
EPINEPHRINE	EPINEPHRINE	HF Acquisition Co LLC, DBA HealthFirst	5726eeca-db88-ba8e-e063-6294a90a927d	2026-08-03	Warnings, Adverse reactions	Name fallback generic name: EPINEPHRINE
EPINEPHRINE	EPINEPHRINE	HF Acquisition Co LLC, DBA HealthFirst	5725a519-3ad6-7e5e-e063-6394a90a111f	2026-07-21	Warnings, Adverse reactions	Name fallback generic name: EPINEPHRINE
EPINEPHRINE	EPINEPHRINE	Fresenius Kabi USA, LLC	4f83895f-638c-4515-af03-7c41ae60a42e	2026-07-15	Warnings, Adverse reactions	Name fallback generic name: EPINEPHRINE
Epinephrine	EPINEPHRINE	A-S Medication Solutions	6e811e28-0199-4df7-a916-5940c632401d	2026-07-13	Warnings, Adverse reactions	Name fallback generic name: EPINEPHRINE
EPINEPHRINE	EPINEPHRINE	CIVICA, INC.	4a79ad00-405b-4454-a692-7f1daac4adec	2026-07-10	Warnings, Adverse reactions	Name fallback generic name: EPINEPHRINE
Epinephrine	EPINEPHRINE	A-S Medication Solutions	386519ba-7a44-4edd-9eb1-748419b7a71b	2026-07-06	Warnings, Adverse reactions	Name fallback generic name: EPINEPHRINE
Adrenalin	EPINEPHRINE	Par Health USA, LLC	3b7a4364-668d-4eb2-a20c-04adc35aabe4	2026-07-01	Warnings, Adverse reactions	Name fallback generic name: EPINEPHRINE
Adrenalin	EPINEPHRINE	REMEDYREPACK INC.	1d89cba4-432b-4a98-8969-5a019dced8d1	2026-06-16	Warnings, Adverse reactions	Name fallback generic name: EPINEPHRINE
Epinephrine	EPINEPHRINE	REMEDYREPACK INC.	0172280c-f7d6-4613-9dbd-f94d3ae5825a	2026-06-08	Warnings, Adverse reactions	Name fallback generic name: EPINEPHRINE
Epinephrine	EPINEPHRINE	Hikma Pharmaceuticals USA Inc.	1e8ebac1-5b32-47f9-a930-86a98a24dccc	2026-05-05	Warnings, Adverse reactions	Name fallback generic name: EPINEPHRINE
Epinephrine	EPINEPHRINE	Sportpharm LLC	3a8f5ca2-6c1d-4011-9266-ba93c7a3abb9	2026-04-24	Warnings, Adverse reactions	Name fallback generic name: EPINEPHRINE
neffy	EPINEPHRINE	Sportpharm LLC	2052f9db-7d76-443b-b702-b6b499f9a4b8	2026-04-24	Warnings, Adverse reactions	Name fallback generic name: EPINEPHRINE
neffy	EPINEPHRINE	ARS Pharmaceuticals Operations, Inc.	a1758142-a905-401d-8961-05829f51023a	2026-04-09	Warnings, Adverse reactions	Name fallback generic name: EPINEPHRINE
Adrenalin	EPINEPHRINE	Par Health USA, LLC	a5ce0c01-dd47-4997-ab09-490de65d3835	2026-04-08	Warnings, Adverse reactions	Name fallback generic name: EPINEPHRINE
Adrenalin	EPINEPHRINE	Par Health USA, LLC	b27e06aa-5b40-44bc-8de7-80b027580a3b	2026-04-08	Warnings, Adverse reactions	Name fallback generic name: EPINEPHRINE
epinephrine	EPINEPHRINE	Baxter Healthcare Corporation	ef556382-9d19-4f0e-9dbe-fcecc772a3e2	2026-03-30	Warnings, Adverse reactions	Name fallback generic name: EPINEPHRINE
epinephrine	EPINEPHRINE	REMEDYREPACK INC.	c66de0d3-3b0f-4e52-a712-60357a107676	2026-03-24	Warnings, Adverse reactions	Name fallback generic name: EPINEPHRINE
epinephrine	EPINEPHRINE	Amneal Pharmaceuticals of New York LLC	e13f05f1-7d21-49bb-b8d5-24bf9301c3d7	2026-03-20	Warnings, Adverse reactions	Name fallback generic name: EPINEPHRINE
epinephrine	EPINEPHRINE	Baxter Healthcare Corporation	60efd409-3555-4182-a68d-1cd7bc0d1bfc	2026-03-16	Warnings, Adverse reactions	Name fallback generic name: EPINEPHRINE
epinephrine	EPINEPHRINE	REMEDYREPACK INC.	bfc7ab3d-1e0e-4fd9-b6df-09603eb5808c	2026-02-18	Warnings, Adverse reactions	Name fallback generic name: EPINEPHRINE

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 18 matching rows.

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
0781-3442	SYMJEPI	Epinephrine	Sandoz Inc.	NDA	Current
0781-3442	SYMJEPI	Epinephrine	Sandoz Inc.	NDA	Current
0781-3442	SYMJEPI	Epinephrine	Sandoz Inc.	NDA	Current
0781-3442	SYMJEPI	Epinephrine	Sandoz Inc.	NDA	Current
0781-3442	SYMJEPI	Epinephrine	Sandoz Inc.	NDA	Current
0781-3448	SYMJEPI	Epinephrine	Sandoz Inc.	NDA	Current
0781-3448	SYMJEPI	Epinephrine	Sandoz Inc.	NDA	Current
0781-3448	SYMJEPI	Epinephrine	Sandoz Inc.	NDA	Current
0781-3448	SYMJEPI	Epinephrine	Sandoz Inc.	NDA	Current
38739-200	SYMJEPI	Epinephrine	Adamis Pharmaceuticals Corporation	NDA	Current
78670-130	Symjepi	epinephrine	USWM, LLC	NDA	Current
78670-130	Symjepi	epinephrine	USWM, LLC	NDA	Current
78670-130	Symjepi	epinephrine	USWM, LLC	NDA	Current
78670-130	Symjepi	epinephrine	USWM, LLC	NDA	Current
78670-131	Symjepi	epinephrine	USWM, LLC	NDA	Current
78670-131	Symjepi	epinephrine	USWM, LLC	NDA	Current
78670-131	Symjepi	epinephrine	USWM, LLC	NDA	Current
78670-131	Symjepi	epinephrine	USWM, LLC	NDA	Current

Documents#

Document, Submission type, Date table
Document	Submission type	Date
67987	SUPPL	2021-06-30
67981	SUPPL	2021-06-30
64424	SUPPL	2020-08-27
55804	SUPPL	2018-10-03
55753	SUPPL	2018-10-01
49517	ORIG	2017-08-23
48731	ORIG	2017-06-16
48725	ORIG	2017-06-15